SILO
Price:
$0.9586
Market Cap:
$4.30M
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal comp...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
NASDAQ
Ticker
SILO
According to Silo Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -62.51%. This represents a change of 299.23% compared to the average of -15.66% of the last 4 quarters.
The mean historical ROE of Silo Pharma, Inc. over the last ten years is 390.28%. The current -62.51% ROE has changed -116.02% with respect to the historical average. Over the past ten years (40 quarters), SILO's ROE was at its highest in in the December 2019 quarter at 1.67%. The ROE was at its lowest in in the June 2019 quarter at -235.28%.
Average
390.28%
Median
-29.35%
Minimum
-244.39%
Maximum
4.58%
Discovering the peaks and valleys of Silo Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 529.14%
Maximum Annual ROE = 4.58%
Minimum Annual Increase = -2024.19%
Minimum Annual ROE = -244.39%
Year | ROE | Change |
---|---|---|
2023 | -59.91% | 58.51% |
2022 | -37.80% | -187.74% |
2021 | 43.08% | -117.63% |
2020 | -244.39% | -105.34% |
2019 | 4.58% | -2024.19% |
2018 | -237.94% | -902.87% |
2017 | 29.64% | -122.54% |
2016 | -131.48% | 529.14% |
2015 | -20.90% | 31.48% |
2014 | -15.90% | -963.87% |
The current ROE of Silo Pharma, Inc. (SILO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-18.21%
5-year avg
855.87%
10-year avg
390.28%
Silo Pharma, Inc.’s ROE is greater than Protagenic Therapeutics, Inc. (-308.96%), greater than Rezolute, Inc. (-69.83%), greater than Lumos Pharma, Inc. (-233.03%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Sino Biopharmaceutical Limited (11.52%), less than Inventiva S.A. (524.89%), less than BioCardia, Inc. (1.00%), less than UroGen Pharma Ltd. (932.03%), greater than Indaptus Therapeutics, Inc. (-177.27%), greater than Tempest Therapeutics, Inc. (-187.44%), less than Comera Life Sciences Holdings, Inc. (67.46%), greater than Forte Biosciences, Inc. (-151.43%), greater than Pardes Biosciences, Inc. (-41.86%), greater than Shattuck Labs, Inc. (-61.92%), less than Eliem Therapeutics, Inc. (0%), less than Champions Oncology, Inc. (66.22%), greater than Century Therapeutics, Inc. (-66.58%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than HOOKIPA Pharma Inc. (-49.25%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Inozyme Pharma, Inc. (-88.42%), greater than Terns Pharmaceuticals, Inc. (-32.76%),
Company | ROE | Market cap |
---|---|---|
-308.96% | $2.91M | |
-69.83% | $255.53M | |
-233.03% | $37.54M | |
-184.40% | $42.01M | |
11.52% | $7.54B | |
524.89% | $208.50M | |
1.00% | $9.17M | |
932.03% | $456.60M | |
-177.27% | $10.92M | |
-187.44% | $37.39M | |
67.46% | $6.15K | |
-151.43% | $28.80M | |
-41.86% | $135.19M | |
-61.92% | $52.99M | |
0% | $342.68M | |
66.22% | $108.76M | |
-66.58% | $87.15M | |
-32.99% | $107.54M | |
-49.25% | $18.30M | |
-22.40% | $1.28B | |
-88.42% | $188.22M | |
-32.76% | $492.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silo Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Silo Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Silo Pharma, Inc.'s ROE?
How is the ROE calculated for Silo Pharma, Inc. (SILO)?
What is the highest ROE for Silo Pharma, Inc. (SILO)?
What is the 3-year average ROE for Silo Pharma, Inc. (SILO)?
What is the 5-year average ROE for Silo Pharma, Inc. (SILO)?
How does the current ROE for Silo Pharma, Inc. (SILO) compare to its historical average?